- Home
- EVAX vs HAO Comparison
EVAX vs HAO Comparison
Compare EVAX & HAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- HAO
- Stock Information
- Founded
- EVAX 2008
- HAO 2018
- Country
- EVAX Denmark
- HAO China
- Employees
- EVAX N/A
- HAO N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- HAO
- Sector
- EVAX Health Care
- HAO
- Exchange
- EVAX Nasdaq
- HAO NYSE
- Market Cap
- EVAX 8.7M
- HAO 7.4M
- IPO Year
- EVAX 2021
- HAO 2024
- Fundamental
- Price
- EVAX $0.89
- HAO $0.10
- Analyst Decision
- EVAX Strong Buy
- HAO
- Analyst Count
- EVAX 2
- HAO 0
- Target Price
- EVAX $11.00
- HAO N/A
- AVG Volume (30 Days)
- EVAX 82.5K
- HAO 7.6M
- Earning Date
- EVAX 10-31-2024
- HAO 10-29-2024
- Dividend Yield
- EVAX N/A
- HAO N/A
- EPS Growth
- EVAX N/A
- HAO 20.20
- EPS
- EVAX N/A
- HAO 0.04
- Revenue
- EVAX $3,295,000.00
- HAO $48,519,836.00
- Revenue This Year
- EVAX $4,845.21
- HAO N/A
- Revenue Next Year
- EVAX $30.30
- HAO N/A
- P/E Ratio
- EVAX N/A
- HAO $2.37
- Revenue Growth
- EVAX N/A
- HAO 71.88
- 52 Week Low
- EVAX $0.85
- HAO $0.09
- 52 Week High
- EVAX $13.61
- HAO $10.60
- Technical
- Relative Strength Index (RSI)
- EVAX 21.83
- HAO 31.41
- Support Level
- EVAX $0.85
- HAO $0.12
- Resistance Level
- EVAX $0.96
- HAO $0.14
- Average True Range (ATR)
- EVAX 0.15
- HAO 0.02
- MACD
- EVAX -0.00
- HAO 0.01
- Stochastic Oscillator
- EVAX 5.75
- HAO 12.12
About EVAX Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About HAO HAOXI HEALTH TECHNOLOGY LTD
Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving leading customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.